- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01706731
Effectiveness of Buddhist Monks in Providing Cognitive Behavior Therapy (Add-CBT)
October 12, 2012 updated by: Nahathai Wongpakaran, Chiang Mai University
A Randomized Controlled Trial of Cognitive Behavior Therapy Provided by Buddhist Monks vs. Treatment as Usual in the Treatment of Late Life-depression
This research is to study the effectiveness of cognitive behavioral therapy-CBT and Psychotherapy by trained buddhist monks.
There are generally accepted that both cognitive and Buddhist concepts are related.
This randomized controlled trial is to study the elderly participants who suffer major depressive disorder according to DSM-IV.
The subjects will be divided into two groups.
The experimental group will receive 12 sessions of CBT 2 times per week for 6 weeks in addition to usual treatment.
The control group will receive treatment as usual and general conversation (non-CBT) with monks.
Pretreatment factors (such as attachment style, interpersonal factors) of both therapist monks and patient participants will be studied.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chiang Mai, Thailand, 50200
- Geriatric clinic, Maharaj Nakorn Chiang Mai Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 95 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Meet criteria for Major depressive disorder
- receiving antidepressant
Exclusion Criteria:
- presence of intense suicidal intent behaviors that require inpatient admission
- history of alcohol or drug dependence
- presence of hallucinations or delusions
- currently receiving electroconvulsive therapy or repetitive-transcranial magnetic stimulation,
- patients' involvement in other clinical trials.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: TAU plus Cognitive-behavioral Therapy
Participants randomized to this group will receive treatment as usual plus cognitive behavioral therapy (CBT) provided by trained Buddhist monks.
|
Treatment as usual (TAU)is defined as the routine care provided to each individual patient at the geriatric psychiatry clinic of Maharaj Nakorn Chiang Mai Hospital.
Other Names:
Cognitive behavioral therapy(CBT)includes psychoeducational components combined with cognitive interventions targeted at challenging negative automatic thoughts.
|
|
SHAM_COMPARATOR: TAU plus routine counselling
Participants randomized into this group will receive treatment as usual (TAU) plus plus routine psychological support from non-CBT monks.
|
Treatment as usual (TAU)is defined as the routine care provided to each individual patient at the geriatric psychiatry clinic of Maharaj Nakorn Chiang Mai Hospital.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evidence of clinically depression confirmed by clinician
Time Frame: 2 months after the end of the intervention
|
Depression will be assessed by HAMD-7 (McIntyre, 2005)
|
2 months after the end of the intervention
|
|
Depression- self report
Time Frame: 2 month after the end of the inetrvention
|
depression will be assessed by Geriatric Depression Scale (GDS)(Shiekh & Yesavage, 1986)
|
2 month after the end of the inetrvention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dimensional psychological distress (anxiety, depression,and somatization)
Time Frame: week 6, 12, 20
|
anxiety, depression,and somatization symptom will be assessed by the Core symptom index (CSI) (Wongpakaran, unpublished),
|
week 6, 12, 20
|
|
Dimensional psychological distress ( perception of stress)
Time Frame: Week 6, 12, 20
|
Perception of stress will be assessed by Perceived Stress Scale-10 (PSS-10) (Cohen 1983 ; Wongpakaran, 2010)
|
Week 6, 12, 20
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
working alliance
Time Frame: after session 3, 6, and 12
|
Working alliance will be assessed by the Helping Alliance Questionnaire (HAQ)(Luborsky, 1996)
|
after session 3, 6, and 12
|
|
Pretreatment measure (attachment)
Time Frame: at baseline
|
The part includes participants' attachment which will be assessed by the revised Experience of Close Relationships Questionnaire (ECR-R 18)(Wongpakaran, 2012)
|
at baseline
|
|
Pretreatment measure (interpersonal problems)
Time Frame: at baseline
|
Interpersonal problems will be assessed by the inventory of interpersonal problems(Horowitz, 2000)
|
at baseline
|
|
Pretreatment measure(neuroticism)
Time Frame: at baseline
|
Neuroticism will be assessed by the Neuroticsm Inventory (Wongpakaran,unpublished)
|
at baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nahathai - Wongpakaran, M.D., Chiang Mai University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (ANTICIPATED)
October 1, 2013
Study Completion (ANTICIPATED)
October 1, 2013
Study Registration Dates
First Submitted
October 8, 2012
First Submitted That Met QC Criteria
October 12, 2012
First Posted (ESTIMATE)
October 15, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
October 15, 2012
Last Update Submitted That Met QC Criteria
October 12, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 918
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Disorder
-
Gang WangWest China Hospital; The First Hospital of Hebei Medical University; Tianjin... and other collaboratorsRecruitingMajor Depressive Disorder (MDD) | Depression - Major Depressive DisorderChina
-
Brian MickeyNational Institute of Mental Health (NIMH)RecruitingMajor Depressive Episode | Depression - Major Depressive Disorder | Treatment-Resistant Major Depressive DisorderUnited States
-
Unity Health TorontoUniversity of Toronto; Toronto Metropolitan UniversityRecruitingMajor Depressive Disorder (MDD) | Major Depressive Episode | Treatment-Resistant Major Depressive DisorderCanada
-
Stanford UniversityNational Institute of Mental Health (NIMH)Recruiting
-
TakedaRecruitingMajor Depressive DisorderJapan
-
Neurocrine BiosciencesRecruitingMajor Depressive DisorderSpain, Serbia, United States, Bulgaria, Canada, Estonia, Italy, Poland, Taiwan, Australia, South Korea
-
Luye Pharma Group Ltd.Enrolling by invitationMajor Depressive DisorderChina
-
NeuroQore Inc.Makromed Inc.Enrolling by invitationMajor Depressive DisorderUnited States
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
The Royal Ottawa Mental Health CentreNot yet recruitingDepression | Major Depressive Disorder (MDD) | Depressive Episode | Depression - Major Depressive DisorderCanada
Clinical Trials on Treatment as usual
-
Universitätsklinikum Hamburg-EppendorfCompletedPerioperative AnxietyGermany
-
University of ChicagoNational Institute of Mental Health (NIMH)Not yet recruitingHIV | Financial Stress
-
South London and Maudsley NHS Foundation TrustCompletedAttention Deficit Hyperactivity DisorderUnited Kingdom
-
McMaster UniversityNot yet recruiting
-
Gaia AGWithdrawnType 2 DiabetesGermany
-
Centre for Addiction and Mental HealthCompleted
-
King's College LondonUnknown
-
University Hospital, AkershusUniversity of OsloActive, not recruiting
-
Universitat Jaume IConsorcio Hospitalario Provincial de CastellónCompletedDepression | AnxietySpain
-
University of IndianapolisUniversity of Missouri, Kansas City; Missouri State UniversityCompletedHypertension | Diabete Type 2United States